IMRA Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (23 vas. 2023 @ 23:00):

IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin...

Stats
Dzisiejszy wolumen	271 721
Średni wolumen	116 259
Kapitalizacja rynkowa	165.80M
EPS	$-0.000510 ( 2023-09-29 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	105.33
ATR14	$0.322 (5.09%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-29	Lyssikatos Joseph P	Sell	12 000	Stock Option (right to buy)
2023-12-29	Lyssikatos Joseph P	Buy	12 000	Common Stock
2023-12-29	Lyssikatos Joseph P	Sell	9 151	Common Stock
2023-12-29	Lyssikatos Joseph P	Sell	2 849	Common Stock
2023-12-28	Patel Anish	Sell	2 520	Common Stock

INSIDER POWER
82.98
Last 97 transactions
Buy: 15 631 291 \| Sell: 878 871

Wolumen Korelacja

Długi: -0.10 (neutral)

Krótki: 0.82 (strong)

Signal:(75.335) Same movement expected

Imara Inc Korelacja

10 Najbardziej pozytywne korelacje
BOCH	0.938
MMAC	0.916
SHSP	0.895
LMST	0.886
NETE	0.885
MNSB	0.859
SMCI	0.857
VOXX	0.844
WSC	0.841
STRL	0.84

10 Najbardziej negatywne korelacje
RMRM	-0.956
TDAC	-0.93
APOP	-0.923
GAINL	-0.91
AEY	-0.888
UK	-0.878
SVOK	-0.873
FANG	-0.865
BNRG	-0.862
HUSN	-0.861

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Imara Inc Korelacja - Waluta/Towar

-0.18
( neutral )

-0.05
( neutral )

0.31
( neutral )

0.34
( neutral )

-0.26
( neutral )

0.05
( neutral )

Imara Inc Finanse

Annual	2022
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$0.240

FY	2022
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$0.240

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-2.06

FY	2020
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-3.53

Financial Reports:

No articles found.

Imara Inc

IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas. IMARA Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.